Cargando…
S114: FEASIBILITY OF HAPLOIDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR PATIENTS WITH SEVERE SICKLE CELL DISEASE WITH END-STAGE RENAL DISEASE (ESRD) ON HEMODIALYSIS
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811865/ http://dx.doi.org/10.1097/01.HS9.0000821424.68427.87 |
| _version_ | 1784644523561844736 |
|---|---|
| author | Gomez Arteaga, A Orfali, N Pasciolla, M Baptiste, A Hsu, J Mayer, S Phillips, A Shore, T van Besien, K |
| author_facet | Gomez Arteaga, A Orfali, N Pasciolla, M Baptiste, A Hsu, J Mayer, S Phillips, A Shore, T van Besien, K |
| author_sort | Gomez Arteaga, A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8811865 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88118652022-02-22 S114: FEASIBILITY OF HAPLOIDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR PATIENTS WITH SEVERE SICKLE CELL DISEASE WITH END-STAGE RENAL DISEASE (ESRD) ON HEMODIALYSIS Gomez Arteaga, A Orfali, N Pasciolla, M Baptiste, A Hsu, J Mayer, S Phillips, A Shore, T van Besien, K Hemasphere Oral Presentations Lippincott Williams & Wilkins 2022-01-31 /pmc/articles/PMC8811865/ http://dx.doi.org/10.1097/01.HS9.0000821424.68427.87 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Presentations Gomez Arteaga, A Orfali, N Pasciolla, M Baptiste, A Hsu, J Mayer, S Phillips, A Shore, T van Besien, K S114: FEASIBILITY OF HAPLOIDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR PATIENTS WITH SEVERE SICKLE CELL DISEASE WITH END-STAGE RENAL DISEASE (ESRD) ON HEMODIALYSIS |
| title | S114: FEASIBILITY OF HAPLOIDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR PATIENTS WITH SEVERE SICKLE CELL DISEASE WITH END-STAGE RENAL DISEASE (ESRD) ON HEMODIALYSIS |
| title_full | S114: FEASIBILITY OF HAPLOIDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR PATIENTS WITH SEVERE SICKLE CELL DISEASE WITH END-STAGE RENAL DISEASE (ESRD) ON HEMODIALYSIS |
| title_fullStr | S114: FEASIBILITY OF HAPLOIDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR PATIENTS WITH SEVERE SICKLE CELL DISEASE WITH END-STAGE RENAL DISEASE (ESRD) ON HEMODIALYSIS |
| title_full_unstemmed | S114: FEASIBILITY OF HAPLOIDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR PATIENTS WITH SEVERE SICKLE CELL DISEASE WITH END-STAGE RENAL DISEASE (ESRD) ON HEMODIALYSIS |
| title_short | S114: FEASIBILITY OF HAPLOIDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR PATIENTS WITH SEVERE SICKLE CELL DISEASE WITH END-STAGE RENAL DISEASE (ESRD) ON HEMODIALYSIS |
| title_sort | s114: feasibility of haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide for patients with severe sickle cell disease with end-stage renal disease (esrd) on hemodialysis |
| topic | Oral Presentations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811865/ http://dx.doi.org/10.1097/01.HS9.0000821424.68427.87 |
| work_keys_str_mv | AT gomezarteagaa s114feasibilityofhaploidenticalallogeneicstemcelltransplantationwithposttransplantcyclophosphamideforpatientswithseveresicklecelldiseasewithendstagerenaldiseaseesrdonhemodialysis AT orfalin s114feasibilityofhaploidenticalallogeneicstemcelltransplantationwithposttransplantcyclophosphamideforpatientswithseveresicklecelldiseasewithendstagerenaldiseaseesrdonhemodialysis AT pasciollam s114feasibilityofhaploidenticalallogeneicstemcelltransplantationwithposttransplantcyclophosphamideforpatientswithseveresicklecelldiseasewithendstagerenaldiseaseesrdonhemodialysis AT baptistea s114feasibilityofhaploidenticalallogeneicstemcelltransplantationwithposttransplantcyclophosphamideforpatientswithseveresicklecelldiseasewithendstagerenaldiseaseesrdonhemodialysis AT hsuj s114feasibilityofhaploidenticalallogeneicstemcelltransplantationwithposttransplantcyclophosphamideforpatientswithseveresicklecelldiseasewithendstagerenaldiseaseesrdonhemodialysis AT mayers s114feasibilityofhaploidenticalallogeneicstemcelltransplantationwithposttransplantcyclophosphamideforpatientswithseveresicklecelldiseasewithendstagerenaldiseaseesrdonhemodialysis AT phillipsa s114feasibilityofhaploidenticalallogeneicstemcelltransplantationwithposttransplantcyclophosphamideforpatientswithseveresicklecelldiseasewithendstagerenaldiseaseesrdonhemodialysis AT shoret s114feasibilityofhaploidenticalallogeneicstemcelltransplantationwithposttransplantcyclophosphamideforpatientswithseveresicklecelldiseasewithendstagerenaldiseaseesrdonhemodialysis AT vanbesienk s114feasibilityofhaploidenticalallogeneicstemcelltransplantationwithposttransplantcyclophosphamideforpatientswithseveresicklecelldiseasewithendstagerenaldiseaseesrdonhemodialysis |